Matches in Nanopublications for { ?s ?p "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP168776.RAC7vgWSLfAe03GDgBfSrIT1wUC3HADo-m99hWg50oZis130_assertion description "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP168776.RAC7vgWSLfAe03GDgBfSrIT1wUC3HADo-m99hWg50oZis130_provenance.
- assertion description "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP562761.RA83sjRUou-UkaV8BZITiOspS1DmQixdYd_AuQJeIHXiM130_assertion description "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562761.RA83sjRUou-UkaV8BZITiOspS1DmQixdYd_AuQJeIHXiM130_provenance.
- NP755034.RA9RYDKX89I4Iuct8NAMh4jgHCn55Cp0cqed92omFadTI130_assertion description "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755034.RA9RYDKX89I4Iuct8NAMh4jgHCn55Cp0cqed92omFadTI130_provenance.
- NP945820.RAeQaupVTl_q2QkAX4ajm7cUvgt7_alBLOCiDWxtyXzJA130_assertion description "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945820.RAeQaupVTl_q2QkAX4ajm7cUvgt7_alBLOCiDWxtyXzJA130_provenance.
- assertion description "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP646297.RAdsvcY-qzt8kCYiy5TQpazL7KmuoXWK9R1yFwnN8DU-k130_assertion description "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646297.RAdsvcY-qzt8kCYiy5TQpazL7KmuoXWK9R1yFwnN8DU-k130_provenance.
- NP802877.RABx-puU0XX0gJce7LcfH2c1rxzL1N0vF8LzzqtRGFpsE130_assertion description "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802877.RABx-puU0XX0gJce7LcfH2c1rxzL1N0vF8LzzqtRGFpsE130_provenance.
- NP853239.RALFpAn76N-_WbLqSaPid2BlLV6qlstSBm0o7f50sSXJs130_assertion description "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853239.RALFpAn76N-_WbLqSaPid2BlLV6qlstSBm0o7f50sSXJs130_provenance.
- NP646296.RAmBgW0YV-v1dIlmg--JrR4Rtpk4OfKlplRUeEo_RFehI130_assertion description "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646296.RAmBgW0YV-v1dIlmg--JrR4Rtpk4OfKlplRUeEo_RFehI130_provenance.
- NP646298.RAkT3XLIkaEmlVB3hiOzuzKizGAu9_QC-JYUlVo1AJPpI130_assertion description "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646298.RAkT3XLIkaEmlVB3hiOzuzKizGAu9_QC-JYUlVo1AJPpI130_provenance.
- NP554018.RA8vUAqZozFPVbAQaIKhx_uh3DnaTUT-4MJcAhNLwvwlE130_assertion description "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554018.RA8vUAqZozFPVbAQaIKhx_uh3DnaTUT-4MJcAhNLwvwlE130_provenance.
- NP646299.RA8Ea1tYWfK-A3a5sLr4FcmTRfDNRY4m5PL5A9xt1MW9o130_assertion description "[MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646299.RA8Ea1tYWfK-A3a5sLr4FcmTRfDNRY4m5PL5A9xt1MW9o130_provenance.